The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future

597 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics (2019, background): “There is growing interest in the potential of psychedelics to treat various psychiatric disorders (Carhart-Harris and Goodwin, 2017; Rucker et al., 2018).”
Psilocybin with psychological support for treatment-resistant depression: six-month follow-up (2017, background): “See Carhart-Harris and Goodwin (2017) for a review of historical and recent trials with psychedelics.”
Serotonin and brain function: a tale of two receptors (2017, background): “…2015b; Muthukumaraswamy et al., 2013) and clinical trials (Bogenschutz et al., 2015; Carhart-Harris et al., 2016a; Gasser et al., 2014; Griffiths et al., 2016; Grob et al., 2011; Mithoefer et al., 2011; Ross et al., 2016; Sanches et al., 2016) – see Carhart-Harris and Goodwin (2017) for a review.”
Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression (2018, background): “Given the growing evidence favoring the therapeutic value of psychedelics (dos Santos et al., 2016; Rucker et al., 2016; Carhart-Harris and Goodwin, 2017), it is timely that we better understand their therapeutic mechanisms.”